Elevated SII is an independent predictor of increased 28-day all-cause mortality in AHF patients, and as a readily available and cost-effective marker, SII could be integrated into early risk stratification protocols to guide personalized therapeutic strategies in acute care settings.
Key Findings
Results
Higher SII tertiles were independently associated with greater 28-day all-cause mortality in AHF patients.
Compared with the lowest tertile, the middle SII tertile had HR = 1.485 (95% CI: 1.193–1.849, P < .01)
The highest SII tertile had HR = 2.497 (95% CI: 2.060–3.028, P < .01)
Associations were assessed using multivariable Cox proportional hazards models adjusting for demographic, clinical, and laboratory covariates
Kaplan-Meier analysis showed significant differences in 28-day mortality across SII tertiles (log-rank P < .001)
Results
SII demonstrated a dose-response relationship with 28-day mortality in AHF patients.
Restricted cubic spline analyses were used to evaluate the shape of the association
Results suggested a dose-response (non-linear or continuous) relationship between SII and 28-day mortality
SII was calculated as (platelet count × neutrophil count)/lymphocyte count from initial admission laboratory values
Results
Elevated SII was similarly associated with increased mortality at 90-, 180-, and 365-day follow-up timepoints.
Similar associations were observed for 90-, 180-, and 365-day mortality beyond the primary 28-day endpoint
This suggests SII has prognostic relevance beyond the acute 28-day period
The study used a retrospective cohort design from the MIMIC-IV database
Results
Adding SII to established severity scores improved discrimination for 28-day mortality.
Adding SII to Acute Physiology Score III (APS III) and Sequential Organ Failure Assessment (SOFA) improved discrimination for 28-day mortality
Improvement was assessed using receiver operating characteristic (ROC) analyses
This suggests SII provides incremental prognostic value beyond standard ICU severity scores
Methods
The study included 5482 AHF patients admitted to the ICU, identified from the MIMIC-IV database.
A total of 5482 patients were included in the final analysis
Inclusion criteria required an AHF diagnosis on first ICU admission
Exclusion criteria included ICU stays < 24 hours or missing key laboratory data
Patients were categorized into tertiles based on their SII values
Zhang C, Zhang Z, Yan Z, Cui H, Ji X, Li J. (2026). Association of systemic immune-inflammation index (SII) with 28-day all-cause mortality in acute heart failure: A retrospective cohort study.. Medicine. https://doi.org/10.1097/MD.0000000000048027